Fresenius Kabi USA, LLC: 0.9% Sodium Chloride Injection, USP 900 mg per 100 mL
Recall reason: Lack of Assurance of Sterility. Recalled by Fresenius Kabi USA, LLC. Distribution: US Nationwide , Alaska, and Puerto Rico.. Classification (Class II — potential health risk). Affected lots/NDC/dates: Batch# 23DU10004, Exp Date: 04/30/2026; Batch# 23HU10006, Exp Date: 06/30/2026.. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report